PHARMACYTE BIOTECH, INC. Accounts Receivable
PHARMACYTE BIOTECH, INC. (PMCB) had Accounts Receivable of $2.58 thousand as of 2012-04-30, per its 10-K filed 2012-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2012-08-14
- 2012-04-30: Accounts Receivable, after Allowance for Credit Loss, Current $2.58K.
- 2011-04-30: Accounts Receivable, after Allowance for Credit Loss, Current $2.32K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2012-04-30 | $2.58K 10-K · filed 2012-08-14 |
| 2011-04-30 | $2.32K 10-K · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |